Low levels of plasma agmatine in the metabolic syndrome

Inho Jo, Changsu Han, Sangmee Ahn Jo, Ji A Seo, Moon Ho Park, Nan Hee Kim

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: The biophysiology of the amino acid l-arginine has been a field of active research. Agmatine, which is a metabolite of l-arginine, is known to participate in many biophysical reactions, including those in the cardiovascular system. We sought to investigate plasma agmatine levels in human subjects as a potential biomarker for the metabolic syndrome. Methods: Agmatine concentration was measured in plasma from 322 elderly participants in the Ansan Geriatric study. The metabolic syndrome was defined according to an Asian modified version of criteria established in the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. We observed that the metabolic syndrome was associated with low levels of plasma agmatine concentration. Results: The mean plasma agmatine level in the metabolic syndrome group was lower than that in the non-metabolic syndrome group (79.42 ng/mL vs. 82.44 ng/mL, P = 0.024). Agmatine remained significant within the regression model after adjustment for different covariates (adjusted odds ratio, 0.962; 95% confidence interval, 0.933-0.993). Conclusions: We concluded that plasma agmatine levels were lower in subjects with the metabolic syndrome than in those without the metabolic syndrome.

Original languageEnglish
Pages (from-to)21-24
Number of pages4
JournalMetabolic Syndrome and Related Disorders
Volume8
Issue number1
DOIs
Publication statusPublished - 2010 Feb 1

Fingerprint

Agmatine
Arginine
Cholesterol
Cardiovascular System
Geriatrics
Biomarkers
Odds Ratio
Confidence Intervals
Education
Amino Acids

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Low levels of plasma agmatine in the metabolic syndrome. / Jo, Inho; Han, Changsu; Ahn Jo, Sangmee; Seo, Ji A; Park, Moon Ho; Kim, Nan Hee.

In: Metabolic Syndrome and Related Disorders, Vol. 8, No. 1, 01.02.2010, p. 21-24.

Research output: Contribution to journalArticle

@article{d1da3a9945be43e3a25c255e0c5299f7,
title = "Low levels of plasma agmatine in the metabolic syndrome",
abstract = "Background: The biophysiology of the amino acid l-arginine has been a field of active research. Agmatine, which is a metabolite of l-arginine, is known to participate in many biophysical reactions, including those in the cardiovascular system. We sought to investigate plasma agmatine levels in human subjects as a potential biomarker for the metabolic syndrome. Methods: Agmatine concentration was measured in plasma from 322 elderly participants in the Ansan Geriatric study. The metabolic syndrome was defined according to an Asian modified version of criteria established in the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. We observed that the metabolic syndrome was associated with low levels of plasma agmatine concentration. Results: The mean plasma agmatine level in the metabolic syndrome group was lower than that in the non-metabolic syndrome group (79.42 ng/mL vs. 82.44 ng/mL, P = 0.024). Agmatine remained significant within the regression model after adjustment for different covariates (adjusted odds ratio, 0.962; 95{\%} confidence interval, 0.933-0.993). Conclusions: We concluded that plasma agmatine levels were lower in subjects with the metabolic syndrome than in those without the metabolic syndrome.",
author = "Inho Jo and Changsu Han and {Ahn Jo}, Sangmee and Seo, {Ji A} and Park, {Moon Ho} and Kim, {Nan Hee}",
year = "2010",
month = "2",
day = "1",
doi = "10.1089/met.2009.0032",
language = "English",
volume = "8",
pages = "21--24",
journal = "Metabolic Syndrome and Related Disorders",
issn = "1540-4196",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Low levels of plasma agmatine in the metabolic syndrome

AU - Jo, Inho

AU - Han, Changsu

AU - Ahn Jo, Sangmee

AU - Seo, Ji A

AU - Park, Moon Ho

AU - Kim, Nan Hee

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Background: The biophysiology of the amino acid l-arginine has been a field of active research. Agmatine, which is a metabolite of l-arginine, is known to participate in many biophysical reactions, including those in the cardiovascular system. We sought to investigate plasma agmatine levels in human subjects as a potential biomarker for the metabolic syndrome. Methods: Agmatine concentration was measured in plasma from 322 elderly participants in the Ansan Geriatric study. The metabolic syndrome was defined according to an Asian modified version of criteria established in the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. We observed that the metabolic syndrome was associated with low levels of plasma agmatine concentration. Results: The mean plasma agmatine level in the metabolic syndrome group was lower than that in the non-metabolic syndrome group (79.42 ng/mL vs. 82.44 ng/mL, P = 0.024). Agmatine remained significant within the regression model after adjustment for different covariates (adjusted odds ratio, 0.962; 95% confidence interval, 0.933-0.993). Conclusions: We concluded that plasma agmatine levels were lower in subjects with the metabolic syndrome than in those without the metabolic syndrome.

AB - Background: The biophysiology of the amino acid l-arginine has been a field of active research. Agmatine, which is a metabolite of l-arginine, is known to participate in many biophysical reactions, including those in the cardiovascular system. We sought to investigate plasma agmatine levels in human subjects as a potential biomarker for the metabolic syndrome. Methods: Agmatine concentration was measured in plasma from 322 elderly participants in the Ansan Geriatric study. The metabolic syndrome was defined according to an Asian modified version of criteria established in the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. We observed that the metabolic syndrome was associated with low levels of plasma agmatine concentration. Results: The mean plasma agmatine level in the metabolic syndrome group was lower than that in the non-metabolic syndrome group (79.42 ng/mL vs. 82.44 ng/mL, P = 0.024). Agmatine remained significant within the regression model after adjustment for different covariates (adjusted odds ratio, 0.962; 95% confidence interval, 0.933-0.993). Conclusions: We concluded that plasma agmatine levels were lower in subjects with the metabolic syndrome than in those without the metabolic syndrome.

UR - http://www.scopus.com/inward/record.url?scp=77649106290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649106290&partnerID=8YFLogxK

U2 - 10.1089/met.2009.0032

DO - 10.1089/met.2009.0032

M3 - Article

VL - 8

SP - 21

EP - 24

JO - Metabolic Syndrome and Related Disorders

JF - Metabolic Syndrome and Related Disorders

SN - 1540-4196

IS - 1

ER -